Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ROSEW
3701
DELISTED
Rosehill Resources Inc.
ROSEW
| $155K | ﹤0.01% |
+142,583
| New | +$175K |
2017 Q2
0 quarters
|
|
3702
DELISTED
Logan Ridge Finance Corp
LRFC
| $154K | ﹤0.01% |
1,982
-153
| -7% | -$12.6K |
2017 Q1
1 quarter
|
|
|
BKEP
3703
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $154K | ﹤0.01% |
24,490
+397
| +2% | +$2.69K |
2015 Q1
9 quarters
|
|
3704
Aurinia Pharmaceuticals
AUPH
$2.21B
| $152K | ﹤0.01% |
24,941
-662
| -3% | -$4.46K |
2017 Q1
1 quarter
|
|
|
CS
3705
DELISTED
Credit Suisse Group
CS
| $152K | ﹤0.01% |
10,475
-2,339
| -18% | -$33.8K |
2016 Q4
2 quarters
|
|
3706
Vivani Medical
VANI
$105M
| $150K | ﹤0.01% |
4,962
-964
| -16% | -$27.3K |
2014 Q4
10 quarters
|
|
|
UQM
3707
DELISTED
UQM Technologies, Inc.
UQM
| $149K | ﹤0.01% |
176,536
| – | – |
2013 Q2
16 quarters
|
|
3708
DELISTED
Delcath Systems Inc
DCTH
| $149K | ﹤0.01% |
+759,089
| New | +$55.5K |
2017 Q2
0 quarters
|
|
|
BNBX
3709
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2014 Q4
10 quarters
|
|
3710
Orion Energy Systems
OESX
$100M
| $148K | ﹤0.01% |
11,615
| – | – |
2013 Q2
16 quarters
|
|
|
SRUNW
3711
DELISTED
Silver Run Acquisition Corporation II
SRUNW
| $148K | ﹤0.01% |
+100,000
| New | +$158K |
2017 Q2
0 quarters
|
|
3712
DELISTED
Bebe Stores Inc
BEBE
| $146K | ﹤0.01% |
24,581
-1,023
| -4% | -$4.86K |
2013 Q2
16 quarters
|
|
|
PME
3713
DELISTED
Pingtan Marine Enterprise Ltd.
PME
| $146K | ﹤0.01% |
37,129
-9,681
| -21% | -$38K |
2015 Q4
6 quarters
|
|
3714
ASE Group
ASX
$115B
| $145K | ﹤0.01% |
23,046
-94,792
| -80% | -$594K |
2015 Q4
6 quarters
|
|
|
PRKR
3715
DELISTED
Parkervision Inc
PRKR
| $145K | ﹤0.01% |
81,220
-1,196
| -1% | -$2.56K |
2013 Q2
16 quarters
|
|
3716
AngloGold Ashanti
AU
$44.9B
| $144K | ﹤0.01% |
+14,950
| New | +$170K |
2017 Q2
0 quarters
|
|
3717
Eterna Therapeutics
ERNA
$2.46M
| $144K | ﹤0.01% |
1
| – | – |
2013 Q2
16 quarters
|
|
3718
Tandem Diabetes Care
TNDM
$1.11B
| $144K | ﹤0.01% |
18,056
+2,515
| +16% | +$23.2K |
2013 Q4
14 quarters
|
|
|
PQ
3719
DELISTED
Petroquest Energy Inc Wd
PQ
| $144K | ﹤0.01% |
73,129
| – | – |
2016 Q2
4 quarters
|
|
|
REXX
3720
DELISTED
Rex Energy Corporation
REXX
| $143K | ﹤0.01% |
49,760
-701
| -1% | -$2.51K |
2013 Q2
16 quarters
|
|
3721
Ellsworth Growth & Income Fund
ECF
$160M
| $140K | ﹤0.01% |
15,447
| – | – |
2013 Q4
14 quarters
|
|
3722
AudioCodes
AUDC
$271M
| $138K | ﹤0.01% |
23,223
-7,195
| -24% | -$46.9K |
2015 Q1
9 quarters
|
|
3723
Lisata Therapeutics
LSTA
$11M
| $134K | ﹤0.01% |
1,933
-29
| -1% | -$2.05K |
2013 Q2
16 quarters
|
|
|
ETRM
3724
DELISTED
EnteroMedics Inc.
ETRM
| $134K | ﹤0.01% |
26,825
-4,776
| -15% | -$23.8K |
2013 Q2
16 quarters
|
|
3725
First US Bancshares
FUSB
$90.3M
| $133K | ﹤0.01% |
11,875
-1,364
| -10% | -$15.9K |
2015 Q4
6 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.